Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Int J Infect Dis ; 143: 107015, 2024 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-38521447

RESUMO

An mpox outbreak was declared in July 2022 by the world health organization (WHO). It causes a mild self-limiting disease however; in immunosuppressed hosts, it tends to cause severe disseminated infection. Most cases of mpox in sold organ transplant (SOT) recipients reported in the literature were treated with tecovirimat. Here we report two cases of severe disseminated mpox infection in renal transplant recipients that were successfully treated with brincidofovir. Both patients were discharged from the hospital with no immediate significant side effects from brincidofovir reported until the submission of this report.


Assuntos
Antivirais , Citosina , Citosina/análogos & derivados , Hospedeiro Imunocomprometido , Transplante de Rim , Organofosfonatos , Humanos , Transplante de Rim/efeitos adversos , Antivirais/uso terapêutico , Citosina/uso terapêutico , Masculino , Organofosfonatos/uso terapêutico , Adulto , Transplantados , Resultado do Tratamento , Pessoa de Meia-Idade
3.
Saudi Med J ; 39(2): 209-212, 2018 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-29436572

RESUMO

Herein, we report a case of a 27-year-old man with Ebstein's anomaly and a history of unexplained recurrent venous thrombosis despite adequate anticoagulation. After surgical correction of the Ebstein's anomaly, the venous thromboembolic events did not recur. This case demonstrates the possible etiopathogenesis of Ebstein's anomaly in causing recurrent venous thromboembolism, which is likely caused through impedance of venous blood flow.Our objective in presenting this particular case is to highlight the possible association between Ebstein's anomaly and venous thrombosis.


Assuntos
Anomalia de Ebstein/complicações , Anomalia de Ebstein/cirurgia , Trombose Venosa/etiologia , Adulto , Anticoagulantes/uso terapêutico , Humanos , Masculino , Recidiva , Trombose Venosa/tratamento farmacológico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA